High Dose Zinc Increases Hospital Admissions Due to Genitourinary Complications
Abstract
Purpose:
Zinc is a common dietary supplement that is widely believed to have beneficial health effects. To assess the impact of high dose supplemental zinc on genitourinary diseases we analyzed a recent randomized trial comparing zinc, antioxidants and their combination to placebo for complications related to the genitourinary tract.
Materials and Methods:
In a further analysis of the recent Age-related Eye Disease Study we examined the data pool for primary International Classification of Diseases, 9th revision codes given for hospital admissions related to urological problems. The Age-Related Eye Disease Study randomized 3,640 patients with age related macular degeneration to 1 of 4 study arms, including placebo, antioxidants (500 mg vitamin C, 400 IU vitamin E and 15 mg β-carotene), 80 mg zinc and antioxidant plus zinc. Statistical analyses using Fisher’s exact test were performed.
Results:
We found a significant increase in hospital admissions due to genitourinary causes in patients on zinc vs nonzinc formulations (11.1% vs 7.6%, p = 0.0003). The risk was greatest in male patients (RR 1.26, 95% CI 1.07–1.50, p = 0.008). In the study group of 343 patients requiring hospital admission the most common primary International Classification of Diseases, 9th revision codes included benign prostatic hyperplasia/urinary retention (benign prostatic hyperplasia), urinary tract infection, urinary lithiasis and renal failure. When comparing zinc to placebo, significant increases in urinary tract infections were found (p = 0.004), especially in females (2.3% vs 0.4%, RR 5.77, 95% CI 1.30–25.66, p = 0.013). Admissions for urinary lithiasis approached significance in men on zinc compared to placebo (2.0% vs 0.5%, RR = 4.08, 95% CI 0.87–19.10). There was no increase in prostate or other cancers with zinc supplementation. A significant decrease in prostate cancer diagnoses was seen in patients receiving antioxidants vs placebo (RR = 0.6, 95% CI 0.49–0.86, p = 0.049). Subgroup analysis revealed that this finding was significant in men who smoked but not in nonsmokers.
Conclusions:
Zinc supplementation at high levels results in increased hospitalizations for urinary complications compared to placebo. These data support the hypothesis that high dose zinc supplementation has a negative effect on select aspects of urinary physiology.
References
- 1 : Zinc intake of the U.S. population: findings from the third National Health and Nutrition Examination Survey, 1988–1994. J Nutr2000; 130: 1367S. Google Scholar
- 2 : Clinical, endocrinologic, and biochemical effects of zinc deficiency. Spec Top Endocrinol Metab1985; 7: 45. Google Scholar
- 3 : Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol1997; 29: 565. Google Scholar
- 4 : Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem. Urol Nurs2004; 24: 49. Google Scholar
- 5 : Diet and benign prostatic hyperplasia: a study in Greece. Urology1999; 54: 284. Google Scholar
- 6 : Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate1999; 40: 200. Google Scholar
- 7 : Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst2003; 95: 1004. Crossref, Medline, Google Scholar
- 8 : Modulation of telomerase activity by zinc in human prostatic and renal cancer cells. Biochem Pharmacol2000; 59: 401. Google Scholar
- 9 : Does zinc supplementation increase the risk of prostate cancer?. Arch Ophthalmol2005; 123: 102. Google Scholar
- 10 : Re: Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst2004; 96: 239. Google Scholar
- 11 : Growth studies of calcium oxalate in the presence of various compounds and ions. II. Br J Urol1970; 42: 296. Google Scholar
- 12 : The role of trace metals in calcium urolithiasis. Invest Urol1977; 14: 347. Google Scholar
- 13 : Role of urinary zinc and copper on calcium oxalate stone formation. Urol Int2004; 72: 233. Google Scholar
- 14 : Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins. Blood1999; 93: 2976. Google Scholar
- 15 : The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol1995; 155: 4143. Google Scholar
- 16 : Excessive intake of zinc impairs immune responses. JAMA1984; 252: 1443. Google Scholar
- 17 : Zinc and the immune system. Proc Nutr Soc2000; 59: 541. Google Scholar
- 18 : A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol2001; 119: 1417. Google Scholar
- 19 : Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr1981; 34: 88. Google Scholar
- 20 : Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol2004; 122: 716. Google Scholar
- 21 : Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate1998; 35: 285. Google Scholar
- 22 : The effect of zinc supplements on lipoproteins and copper status. Atherosclerosis1988; 70: 247. Google Scholar
- 23 : Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev1999; 8: 887. Medline, Google Scholar
- 24 : Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr1995; 62: 1427S. Google Scholar
